In this issue:
Serum IL-9 levels and infliximab efficacy in CD
Recurrence in CD patients after intestinal resection
Comparison of biologicals for induction and maintenance of mucosal healing
Autologous haematopoietic stem cell therapy for refractory CD
Tofacitinib as induction and maintenance therapy for UC
Vitamin D supplementation in IBD
Safety of vedolizumab for UC and CD
Distance to specialist care and disease outcomes in IBD
Antidepressants in IBD
Efficacy of probiotics in IBD
Science blog: JAK-STAT signalling – A target for IBD treatment
Please login below to download this issue (PDF)